verapamil has been researched along with Injuries in 4 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Injuries: Used with anatomic headings, animals, and sports for wounds and injuries. Excludes cell damage, for which pathology is used.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The authors showed that verapamil has the ability to improve wound healing by enhancing fibroblast proliferation, collagen bundle synthesis, and revascularization in skin injuries." | 3.83 | Verapamil, a Calcium-Channel Blocker, Improves the Wound Healing Process in Rats with Excisional Full-Thickness Skin Wounds Based on Stereological Parameters. ( Ashkani-Esfahani, S; Fatheazam, R; Hosseinabadi, OK; Kardeh, S; Khoshneviszadeh, M; Mehrvarz, S; Moafpourian, Y; Moezzi, P; Nadimi, E; Noorafshan, A; Rafiee, S, 2016) |
| "Losartan was the only medication that showed significantly lower levels of albuminuria after 1 week (P < 0." | 2.84 | A randomised controlled trial evaluating renal protective effects of selenium with vitamins A, C, E, verapamil, and losartan against extracorporeal shockwave lithotripsy-induced renal injury. ( Awadalla, A; Barakat, TS; El-Ghar, MA; El-Nahas, AR; Elsaadany, MM; Elsawy, EA; Elshal, AM; Ismail, AM; Saleh, HH; Sheir, KZ; Taha, DE; Wafa, EW, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rha, EY | 1 |
| Kim, YH | 1 |
| Kim, TJ | 1 |
| Yoo, G | 1 |
| Rhie, JW | 1 |
| Kim, HJ | 1 |
| Park, IK | 1 |
| Ashkani-Esfahani, S | 1 |
| Hosseinabadi, OK | 1 |
| Moezzi, P | 1 |
| Moafpourian, Y | 1 |
| Kardeh, S | 1 |
| Rafiee, S | 1 |
| Fatheazam, R | 1 |
| Noorafshan, A | 1 |
| Nadimi, E | 1 |
| Mehrvarz, S | 1 |
| Khoshneviszadeh, M | 2 |
| El-Nahas, AR | 1 |
| Elsaadany, MM | 1 |
| Taha, DE | 1 |
| Elshal, AM | 1 |
| El-Ghar, MA | 1 |
| Ismail, AM | 1 |
| Elsawy, EA | 1 |
| Saleh, HH | 1 |
| Wafa, EW | 1 |
| Awadalla, A | 1 |
| Barakat, TS | 1 |
| Sheir, KZ | 1 |
| Hoyt, DB | 1 |
| Ozkan, AN | 1 |
| Frevert, J | 1 |
| Junger, WG | 1 |
| Loomis, WH | 1 |
1 trial available for verapamil and Injuries
| Article | Year |
|---|---|
A randomised controlled trial evaluating renal protective effects of selenium with vitamins A, C, E, verapamil, and losartan against extracorporeal shockwave lithotripsy-induced renal injury.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Antioxidants; Ascorbic Acid; Calcium Channel Blocker | 2017 |
3 other studies available for verapamil and Injuries
| Article | Year |
|---|---|
Topical Application of a Silicone Gel Sheet with Verapamil Microparticles in a Rabbit Model of Hypertrophic Scar.
Topics: Administration, Topical; Animals; Cell-Derived Microparticles; Cicatrix, Hypertrophic; Disease Model | 2016 |
Verapamil, a Calcium-Channel Blocker, Improves the Wound Healing Process in Rats with Excisional Full-Thickness Skin Wounds Based on Stereological Parameters.
Topics: Administration, Topical; Animals; Biopsy, Needle; Calcium Channel Blockers; Disease Models, Animal; | 2016 |
Alteration in Ca2+ homeostasis by a trauma peptide.
Topics: Calcium; Calcium Channel Blockers; Dantrolene; Fibronectins; Glycopeptides; Homeostasis; Humans; Ino | 1991 |